The aim of this work was to conduct a systematic review and meta-analysis of studies reporting on the risk of traumatic intracerebral hemorrhage (tICH), the course of tICH, and its treatment and mortality rates in elderly mild traumatic brain injury (mTBI) patients using direct oral anticoagulants (DOACs). We consulted PubMed and Embase for relevant cohort and case-control studies with a control group. Two authors independently selected studies, assessed methodological quality, and extracted outcome data. Estimates were pooled with the Mantel-Haenszel random-effects method. We identified 16 articles comprising 3671 elderly mTBI patients using DOACs. Use of DOACs was associated with a reduced risk of tICH compared to the use of vitamin K antagonists (VKAs; odds ratio [OR], 0.44; 95% confidence interval [CI], 0.29–0.65; I2 = 22%) and a similar risk compared to the use of antiplatelet therapy (APT; OR, 0.98; 95% CI, 0.39–2.44; I2 = 0%). Reversal agent use and neurosurgical intervention rate were lower in patients using DOACs compared to patients using VKAs (OR, 0.10; 95% CI, 0.06–0.16; I2 = 0% and OR, 0.37; 95% CI, 0.21–0.67; I2 = 0%, respectively). There was no significant difference in neurosurgical intervention rate between patients who used DOACs versus patients who used APT (OR, 0.58; 95% CI, 0.15–2.21; I2 = 41%) or no antithrombotic therapy (OR, 0.76; 95% CI, 0.20–2.86; I2 = 23%). ICH progression, risk of delayed ICH, and TBI-related in-hospital mortality were comparable among treatment groups. The present study indicates that elderly patients using DOACs have a lower risk of adverse outcome compared to patients using VKAs and a similar risk compared to patients using APT after mTBI.
Get full access to this article
View all access options for this article.
References
1.
LangloisJ.A., Rutland-BrownW., and WaldM.M. (2006). The epidemiology and impact of traumatic brain injury: a brief overview. J. Head Trauma Rehabil. 21, 375–378.
2.
StyrkeJ., StålnackeB.M., SojkaP., and BjörnstigU. (2007). Traumatic brain injuries in a well-defined population: epidemiological aspects and severity. J. Neurotrauma, 24, 1425–1436.
3.
TaylorC.A., BellJ.M., BreidingM.J., and XuL. (2017). Traumatic brain injury-related emergency department visits, hospitalizations, and deaths—United States, 2007 and 2013. Morbid. Mortal. Wkly. Rep. 66, 1–16.
4.
Centers for Disease Control and Prevention. (2014). Report to Congress on Traumatic Brain Injury in the United States: Epidemiology and Rehabilitation. National Center for Injury Prevention and Control, Division of Unintentional Injury Prevention: Atlanta, GA. www.cdc.gov/traumaticbraininjury/pubs/congress_epi_rehab.html (Last accessed: June, 6, 2021).
5.
FaulM., XuL., WaldM.M., CoronadoV., and DellingerA.M. (2010). Traumatic brain injury in the United States: national estimates of prevalence and incidence, 2002–2006. Inj. Prev. 16, A268.
6.
RamanathanD.M., McWilliamsN., SchatzP., and HillaryF.G. (2012). Epidemiological shifts in elderly traumatic brain injury: 18-year trends in Pennsylvania. J. Neurotrauma, 29, 1371–1378.
7.
Dams-O'ConnorK., GibbonsL.E., LandauA., LarsonE.B., and CraneP.K. (2016). Health problems precede traumatic brain injury in older adults. J. Am. Geriatr. Soc. 64, 844–848.
8.
CohenD.B., RinkerC., and WilbergerJ.E. (2006). Traumatic brain injury in anticoagulated patients. J. Trauma, 60, 553–557.
9.
LiJ., BrownJ., and LevineM. (2001). Mild head injury, anticoagulants, and risk of intracranial injury. Lancet, 357, 771–772.
10.
MinhasH., WelsherA., TurcotteM., EventovM., MasonS., NishijimaD.K., VersméeG., LiM., and de WitK. (2018). Incidence of intracranial bleeding in anticoagulated patients with minor head injury: a systematic review and meta-analysis of prospective studies. Br. J. Haematol. 183, 119–126.
11.
van den BrandC.L., TolidoT., RambachA.H., HuninkM.G., PatkaP., & JellemaK. (2017). Systematic review and meta-analysis: is pre-injury antiplatelet therapy associated with traumatic intracranial hemorrhage?. J. Neurotrauma, 34, 1–7.
12.
BarnesG.D., LucasE., AlexanderG.C., and GoldbergerZ.D. (2015). National trends in ambulatory oral anticoagulant use. Am. J. Med. 128, 1300–1305.e2.
13.
Centers for Disease Control and Prevention's (CDC) and American College of Emergency Physicians (ACEP). (2016). Mild TBI Clinical Policy for adults. www.cdc.gov/traumaticbraininjury/pdf/TBI_Clinicians_Factsheet-a.pdf (Last accessed June6, 2021).
14.
Federation of Medical Specialists (2010). Mild traumatic head/brain injury (MHI/mTBI). richtlijnendatabase.nl/richtlijn/licht_traumatisch_hoofd_hersenletsel_lth/licht_traumatisch_hoofd_hersenletsel_-_startpagina.html#algemeen (Last accessed June6, 2021).
15.
UKNCGC. (2014). Head Injury: TriageAssessment, Investigation and Early Management of Head Injury inChildren, Young People andAdults. www.nice.org.uk/guidance/CG176 (Last accessed June6, 2021).
16.
MoherD., LiberatiA., TetzlaffJ., and AltmanD.G.; PRISMAGroup. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6, e1000097.
17.
StroupD.F., BerlinJ.A., MortonS.C., OlkinI., WilliamsonG.D., RennieD., MoherD., BeckerB.J., SipeT.A., and ThackerS.B. (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283, 2008–2012.
18.
SantingJ.A.L., LeeY.X., van der NaaltJ., van den BrandC.L., and JellemaK. (2021). Mild traumatic brain injury in elderly patients receiving direct oral anticoagulants: a systematic review and meta-analysis. PROSPERO 2021 CRD. www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021261933 (Last accessed February1, 2022).
19.
WellsG.A., WellsG., SheaB., SheaB., O'ConnellD., PetersonJ., WelchLosos, M., TugwellP., GaS.W., ZelloG.A., and PetersenJ.A. (2014). The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses.www.ohri.ca/programs/clinical_epidemiology/oxford.asp (Last accessed June6, 2021).
20.
RiccardiA., SpinolaB., MinutoP., GhinattiM., GuiddoG., MalerbaM., and LerzaR. (2017). Intracranial complications after minor head injury (MHI) in patients taking vitamin K antagonists (VKA) or direct oral anticoagulants (DOACs). Am. J. Emerg. Med. 35, 1317–1319.
21.
BeynonC., SakowitzO.W., StörzingerD., OrakciogluB., RadbruchA., PotzyA., and UnterbergA.W. (2015). Intracranial haemorrhage in patients treated with direct oral anticoagulants. Thromb. Res. 136, 560–565.
22.
BillingsJ.D., KhanA.D., McVickerJ.H., and SchroeppelT.J. (2020). Newer and better?. Comparing direct oral anticoagulants to warfarin in patients with traumatic intracranial hemorrhage. Am. Surg. 86, 1062–1066.
23.
CiprianoA., ParkN., PecoriA., BiondaA., BardiniM., FrassiF., LamiV., LeoliF., MancaM.L., Del PratoS., SantiniM., and GhiadoniL. (2021). Predictors of post-traumatic complication of mild brain injury in anticoagulated patients: DOACs are safer than VKAs. Intern. Emerg. Med. 16, 1061–1070.
24.
CoccaA.T., PrivetteA., LeonS.M., CrookesB.A., HallG., LenaJ., and ErikssonE.A. (2019). Delayed intracranial hemorrhage in anticoagulated geriatric patients after ground level falls. J. Emerg. Med. 57, 812–816.
25.
CohanC.M., BeattieG., BowmanJ.A., GalanteJ.M., KwokA.M., DirksR.C., KornblithL.Z., PlevinR., BrowderT.D., and VictorinoG.P. (2020). Repeat computed tomography head scan is not indicated in trauma patients taking novel anticoagulation: a multicenter study. J. Trauma Acute Care Surg. 89, 301–310.
26.
CohanC.M., BeattieG., DominguezD.A., GlassM., PalmerB., and VictorinoG.P. (2020). Routine repeat head CT does not change management in trauma patients on novel anticoagulants. J. Surg. Res. 249, 114–120.
27.
FeeneyJ.M., SantoneE., DiFioriM., KisL., JayaramanV., and MontgomeryS.C. (2016). Compared to warfarin, direct oral anticoagulants are associated with lower mortality in patients with blunt traumatic intracranial hemorrhage: a TQIP study. J. Trauma Acute Care Surg. 81, 843–848.
28.
GalliazzoS., BianchiM.D., ViranoA., TrucchiA., DonadiniM.P., DentaliF., BertùL., GrandiA.M., and AgenoW. (2019). Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs. Thromb. Res. 174, 113–120.
29.
JentzschT., MoosR.M., NeuhausV., HusseinK., Farei-CampagnaJ., SeifertB., SimmenH.P., WernerC., and OsterhoffG. (2018). Is rivaroxaban associated with higher morbidity and mortality in patients with traumatic head injuries?. A retrospective cohort study comparing rivaroxaban, no, anticoagulation, and phenprocoumon. Clin. Neurol. Neurosurg. 169, 116–120.
30.
ParraM.W., ZuckerL., JohnsonE.S., GullettD., AvilaC., WichnerZ.A., and KokaramC.R. (2013). Dabigatran bleed risk with closed head injuries: are we prepared?. J. Neurosurg. 119, 760–765.
31.
PozzessereA., GrottsJ., and KaminskiS. (2015). Dabigatran use does not increase intracranial hemorrhage in traumatic geriatric falls when compared with warfarin. Am. Surg. 81, 1039–1042.
32.
PrexlO., BruckbauerM., VoelckelW., GrottkeO., PonschabM., MaegeleM., & SchöchlH. (2018). The impact of direct oral anticoagulants in traumatic brain injury patients greater than 60-years-old. Scand. J. Trauma Resusc. Emerg. Med. 26, 20.
33.
SavioliG., CeresaI.F., LuzziS., GragnanielloC., Giotta LuciferoA., Del MaestroM., MarascoS., ManzoniF., CiceriL., GelfiE., RicevutiG., and BressanM.A. (2020). Rates of intracranial hemorrhage in mild head trauma patients presenting to emergency department and their management: a comparison of direct oral anticoagulant drugs with vitamin K antagonists. Medicina (Kaunas), 56, 308.
34.
ShinS.S., MarshE.B., AliH., NyquistP.A., HanleyD.F., and ZiaiW.C. (2020). Comparison of traumatic intracranial hemorrhage expansion and outcomes among patients on direct oral anticoagulants versus vitamin K antagonists. Neurocrit. Care, 32, 407–418.
35.
SpinolaM.B., RiccardiA., MinutoP., CampodonicoP., MottaG., MalerbaM., GuiddoG., and LerzaR. (2019). Hemorrhagic risk and intracranial complications in patients with minor head injury (MHI) taking different oral anticoagulants. Am. J. Emerg. Med. 37, 1677–1680.
36.
TurcatoG., ZannoniM., ZaboliA., ZorziE., RicciG., PfeiferN., MaccagnaniA., TenciA., and BonoraA. (2019). Direct oral anticoagulant treatment and mild traumatic brain injury: risk of early and delayed bleeding and the severity of injuries compared with vitamin K antagonists. J. Emerg. Med. 57, 817–824.
37.
KobayashiL., BarmparasG., BosargeP., BrownC.V., BukurM., CarrickM.M., CatalanoR.D., Holly-NicolasJ., InabaK., KaminskiS., KleinA.L., KopelmanT., LeyE.J., MartinezE.M., MooreF.O., MurryJ., NirulaR., PaulD., QuickJ., RiveraO., SchreiberM., andCoimbraR.; AAST Multicenter Prospective Observational Study of Trauma Patients on Novel Oral Anticoagulants StudyGroup. (2017). Novel oral anticoagulants and trauma: the results of a prospective American Association for the Surgery of Trauma Multi-Institutional Trial. J. Trauma Acute Care Surg. 82, 827–835.
38.
NishijimaD.K., ZehtabchiS., BerrongJ., and LegomeE. (2012). Utility of platelet transfusion in adult patients with traumatic intracranial hemorrhage and preinjury antiplatelet use: a systematic review. J. Trauma Acute Care Surg. 72, 1658–1663.
39.
TomaselliG.F., MahaffeyK.W., CukerA., DobeshP.P., DohertyJ.U., EikelboomJ.W., FloridoR., GluckmanT.J., HuckerW.J., MehranR., MesséS.R., PerinoA.C., RodriguezF., SarodeR., SiegalD.M., and WigginsB.S. (2020). 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: a report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. 76, 594–622.
40.
RaoM.P., VinereanuD., WojdylaD.M., AlexanderJ.H., AtarD., HylekE.M., HannaM., WallentinL., LopesR.D., GershB.J., and GrangerC.B.; Apixaban for Reduction in Stroke Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Investigators. (2018). Clinical outcomes and history of fall in patients with atrial fibrillation treated with oral anticoagulation: insights from the ARISTOTLE Trial. Am. J. Med. 131, 269–275.e2.
41.
MüllerM., ChaniasI., NaglerM., ExadaktylosA.K., and SauterT.C. (2021). Falls in ED patients: do elderly patients on direct oral anticoagulants bleed less than those on vitamin K antagonists?. Scand. J. Trauma Resusc. Emerg. Med. 29, 56.
42.
SardarP., ChatterjeeS., WuW.C., LichsteinE., GhoshJ., AikatS., and MukherjeeD. (2013). New oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisons. PLoS One, 8, e77694.
43.
ChatterjeeS., SardarP., Biondi-ZoccaiG., and KumbhaniD.J. (2013). New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation. JAMA Neurol. 70, 1486–1490.
44.
HuangW.Y., SingerD.E., WuY.L., ChiangC.E., WengH.H., LeeM., and OvbiageleB. (2018). Association of intracranial hemorrhage risk with non-vitamin K antagonist oral anticoagulant use vs aspirin use: a systematic review and meta-analysis. JAMA Neurol. 75, 1511–1518.
45.
NederpeltC.J., van der AalstS., RosenthalM.G., KrijnenP., HuismanM.V., PeulW.C., and SchipperI.B. (2020). Consequences of pre-injury utilization of direct oral anticoagulants in patients with traumatic brain injury: a systematic review and meta-analysis. J. Trauma Acute Care Surg. 88, 186–194.
46.
FullerG.W., EvansR., PrestonL., WoodsH.B., and MasonS. (2019). Should adults with mild head injury who are receiving direct oral anticoagulants undergo computed tomography scanning?. A systematic review. Ann. Emerg. Med. 73, 66–75.
47.
FiorelliE.M., BozzanoV., BonziM., RossiS.V., ColomboG., RadiciG., CaniniT., KuriharaH., CasazzaG., SolbiatiM., and CostantinoG. (2020). Incremental risk of intracranial hemorrhage after mild traumatic brain injury in patients on antiplatelet therapy: systematic review and meta-analysis. J. Emerg. Med. 59, 843–855.
48.
ThanM., HerbertM., FlawsD., CullenL., HessE., HollanderJ.E., DiercksD., ArdaghM.W., KlineJ.A., MunroZ., and JaffeA. (2013). What is an acceptable risk of major adverse cardiac event in chest pain patients soon after discharge from the Emergency Department?. A clinical survey. Int. J. Cardiol. 166, 752–754.
49.
AndruchowJ.E., RajaA.S., PrevedelloL.M., ZaneR.D., and KhorasaniR. (2012). Variation in head computed tomography use for emergency department trauma patients and physician risk tolerance. Arch. Intern. Med. 172, 660–661.
WongA.C., KowalenkoT., Roahen-HarrisonS., SmithB., MaioR.F., and StanleyR.M. (2011). A survey of emergency physicians' fear of malpractice and its association with the decision to order computed tomography scans for children with minor head trauma. Pediatr. Emerg. Care, 27, 182–185.
52.
BateyM., HechtJ., CallahanC., and WahlW. (2018). Direct oral anticoagulants do not worsen traumatic brain injury after low-level falls in the elderly. Surgery, 164, 814–819.
53.
VosP.E., AlekseenkoY., BattistinL., EhlerE., GerstenbrandF., MuresanuD.F., PotapovA., StepanC.A., TraubnerP., VecseiL., and vonWild, K.; European Federation of NeurologicalSocieties. (2012). Mild traumatic brain injury. Eur. J. Neurol. 19, 191–198.
54.
MendittoV.G., LucciM., PolonaraS., PomponioG., and GabrielliA. (2012). Management of minor head injury in patients receiving oral anticoagulant therapy: a prospective study of a 24-hour observation protocol. Ann. Emerg. Med. 59, 451–455.
55.
ChaunyJ.M., MarquisM., BernardF., WilliamsonD., AlbertM., LarocheM., and DaoustR. (2016). Risk of delayed intracranial hemorrhage in anticoagulated patients with mild traumatic brain injury: systematic review and meta-analysis. J. Emerg. Med. 51, 519–528.
56.
ColomboG., BonziM., FiorelliE., JachettiA., BozzanoV., CasazzaG., SolbiatiM., and CostantinoG. (2021). Incidence of delayed bleeding in patients on antiplatelet therapy after mild traumatic brain injury: a systematic review and meta-analysis. Scand. J. Trauma Resusc. Emerg. Med., 29(1),123.
57.
HickeyS., HickmanZ.L., ConwayJ., and GiwaA. (2021). The effect of direct oral anti-coagulants on delayed traumatic intracranial hemorrhage after mild traumatic brain injury: a systematic review. J. Emerg. Med. 60, 321–330.
58.
HoogerduijnJ.G., SchuurmansM.J., DuijnsteeM.S., de RooijS.E., and GrypdonckM.F. (2007). A systematic review of predictors and screening instruments to identify older hospitalized patients at risk for functional decline. J. Clin. Nurs. 16, 46–57.
59.
BoydC.M., LandefeldC.S., CounsellS.R., PalmerR.M., FortinskyR.H., KresevicD., BurantC., and CovinskyK.E. (2008). Recovery of activities of daily living in older adults after hospitalization for acute medical illness. J. Am. Geriatr. Soc. 56, 2171–2179.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
